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Factors influencing the formation of urinary carbon dioxide ten-
sion. The factors controlling the formation of urinary carbon diox-
ide tension (Pco2) during sodium bicarbonate administration were
studied in dogs. In highly alkaline urine (pH > 7.8), urine-blood
(U-B) Pco2 rose in both normal and thyroparathyroidectomized
(TPTX) dogs despite a significant difference in urinary phosphate
concentration and excretion. Neutral phosphate infusion in dogs
with highly alkaline urine increased phosphate excretion to 100
.smole/min, but U-B Pco2 was unchanged. In lithium-treated dogs
with highly alkaline urine, U-B Pco2 was significantly lower than
in normal dogs both before and after phosphate infusion. In mod-
erately alkaline urine (urine p1-I, 6.8 to 7.4), phosphate infusion
resulted in a significant increase in U-B Pco2 in normal and lith-
ium-treated dogs but failed to elicit the same response in the post-
obstructed kidney. In acid urine, phosphate infusion failed to raise
urinary Pco2. Acute reduction in glomerular filtration rate, bi-
carbonate, and phosphate excretion caused by acute elevation of
ureteral pressure or acute thoracic inferior vena cava constriction
was not associated wtih any change in U-B Pco2. The ability to
raise U-B Pco2 was also intact in adrenalectomized and hyperka-
lemic dogs. These data demonstrate that urinary Pco2 in highly
alkaline urine is not influenced by glomerular filtration rate, distal
delivery of bicarbonate, bicarbonate excretion, decreases in urine
flow, urinary phosphate concentration and excretion, aldosterone
deficiency, and hyperkalemia. Thus, the formation of urinary Pco2
in highly alkaline urine requires only an intact acidification mecha-
nism. These data also demonstrate that phosphate infusion raises
urinary Pco2 only when the pH of the urine is close to the pK of
the phosphate system (6.8). The data suggest that phosphate in-
fusion when the urine is moderately alkaline may raise urinary
Pco2 in the gradient type of distal renal tubular acidosis, but not in
the secretory type.
Facteurs qui influencent Ia formation de Ia pression partielle de
CO2 de I'urine. Les facteurs qui contrôlent Ia formation de Ia Pco2
urinaire au cours de l'administration de bicarbonate de sodium ont
été étudiés chez des chiens. Dans l'urine trés alcaline (pH > 7,8) Ia
difference de Pco2 urine-sang (U-B) augmente chez les chiens
normaux et les chiens thyroparathyroidectomisés (TPTX) malgré
une difference significative de concentration et d'excrétion un-
naires de phosphates. La perfusion de phosphate neutre a des
chiens excrétant une urine alcaline augmente l'excrétion de phos-
phate jusqu'a lOOt.smoles/min mais U-B Pco2 est inchangé. Chez
les chiens traités par le lithium et excrétant une urine alcaline U-B
Pco2 est significativement inférieur par comparaison avec les
chiens normaux soumis ou non a Ia perfusion de phosphate.
Quand les urines sont modérément alcalines (pH de l'urine, 6.8 a
7, 4) Ia perfusion de phosphate a pour consequence une augmenta-
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tion significative de U-B Pco2 chez les chiens normaux et ceux
traités par Ic lithium mais elle n'induit pas Ia même réponse sur le
rein après levee d'obstacle. En urine acide a perfusion de phosphate
ne determine pas d'augmentation de Ia Pco2 de l'urine. La reduction
aiguë do debit de filtration glomérulaire et des excretions de bicarbon-
ate et de phosphate dCterminée par one augmentation brusque de Ia
pression urétérale ou one constriction de Ia veine cave inférieure
dans son trajet thoracique ne sont pas associés a une modification
de U-B Pco2. La capacité d'augmenter U-B Pco2 est conservée
chez les chiens surrénalectomisés et chez les chiens hyperkalie-
miques. Ces observations montrent que Ia Pco2 urinaire, dans
I'utine très alcaline, n'est pas influencée par les facteurs suivants
debit de filtration glomérulaire, debit distal de bicarbonate, dimi-
nution du debit urinaire, concentration et excretion urinaires de
phosphate, deficit en aldostérone et hyperkaliémie. Ainsi Ia forma-
tion de Pco2 urinaire en urine très alcaline exige seulement un
mécanisme d'acidification intact. Ces résultats montrent aussi que
Ia perfusion de phosphste n'augmente Ia Pco2 que si le pH de
l'unine est voisin du pK des phosphates (6,8). Les résultats suggè-
rent que Ia perfusion de phosphate peut augmenter Ia Pco2 un-
naire, quand l'unine est modérément alcaline, dans l'acidose tubu-
laire rénale oü Ic gradient est affecté mais non dans celle de type
secrétoire.
Pitts and Lotspeich [1] first demonstrated that dur-
ing sodium bicarbonate administration, urinary car-
bon dioxide tension (Pco2) was considerably greater
than the plasma Pco2. They attributed the high
urinary Pco2 of alkaline urine to delayed dehydration
of carbonic acid since carbonic anhydrase adminis-
tration abolished the high urine-blood Pco2 gradient
[2]. Kennedy, Eden, and Berliner showed that a di-
rect relationship exists between urinary Pco2 and
urinary buffer concentration [3]. Based on this obser-
vation, they suggested that buffer delays the dehy-
dration of carbonic acid, and the presence of buffer is
essential for obtaining a high urinary Pco2 [4]. More
recently, Halperin et a! [5] found that patients with
distal renal tubular acidosis failed to raise urinary
Pco2 during sodium bicarbonate administration.
They proposed that urinary Pco2 levels can be used
to assess distal hydrogen ion secretion provided the
urine is alkaline. They interpreted the failure to raise
urinary Pco2 as indicating absent or diminished hy-
drogen ion secretion in the collecting duct, since in
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Table 1. Urinary Pco2 in normal, thyroparathyroidectomized (TPTX) dogs, and
Urine Plasma
flow GFR HC03 PC02 Urine
Group mi/mm mi/mm mEq/liter mm Hg pH
Normal (N = 18) 2.3 + 0.3
P<0.01
54.1 + 4.1
NS
34.8 0.9
NS
40.5 + 1.0
NS
8.02 + 0.02
NS
TPTX (N = 6) 0.6 + 0.1 49.1 + 6.2 33.0 + 0.7 44.3 1.7 7.95 + 0.04
Normal + P04 (N = 6)
Control 5.4 + 1.5
NS
52.7 + 8.8
NS
37.8 2.2
NS
40.8 + 1.4
NS
7.96 + 0.03
NS
P04 4.5 1.0 50.6 + 8.2 38.6 + 1.5 42.8 + 1.5 7.89 0.05
Li + P04 (N = 6)
Control 11.8 2.8
NS
56.0 5.5
NS
44.3 + 3.3
NS
38.6 1.5
NS
7.92 + 0.01
NS
P04 9.3 + 1.9 53.0 4.9 42.2 0.2 39.2 + 1.3 7.92 0.02
GFR glomerular filtration rate: Pco2 and U-Pco2 arterial blood and urine CO2 tension, respectively; UHCO3 and
centration and excretion, respectively.
alkaline urine there is a favorable gradient for hydro-
gen ion secretion. Sebastian, McSherry, and Morris
pointed out that a low urinary Pco2 in the presence of
alkaline urine could also occur as a consequence of
increased acid back diffusion (gradient defect) [6].
This study was designed to examine the factors con-
trolling the formation of urinary PCO2 under normal
conditions and in the presence of induced acid-
ification defects.
Methods
Ninety-one experiments were performed on 85 fe-
male, mongrel dogs. The dogs were anesthetized with
an i.v. injection of sodium pentobarbital, 30 mg/kg
of body wt; light anesthesia, as judged by preserva-
tion of the corneal reflexes, was maintained by sub-
sequent small doses. An endotracheal tube was in-
serted and connected to a respirator (Bird); plasma
Pco2 was maintained between 35 and 45 mm Hg by
appropriate manipulation of the respirator. An arte-
rial catheter was used to record blood pressure and to
sample blood. A peripheral vein catheter was used to
infuse 0.9% saline containing '251-iothalamate (100
tCi/liter) at a rate of 0.6 mI/mm throughout the
experiment as a marker of glomerular filtration rate
Table 2. Plasma electrolyte concentrations in lithium-treated dogsa
Na
mEq/
liter
K
mEq/
liter
Cl
mEq/
liter
HC0
mEq/
liter
Arterial
pH
Urine
pH
Li
mEq/
liter
140.4 3.2 112.8 16.1 7.23 7.26 4.0
+
0.8 0.1 1.1 0.9 0.02 0.09 0.6
Data from all lithium-treated dogs.
(GFR). Sodium bicarbonate (0.9 mole) was infused at
varying rates to achieve the desired urine pH. An
equilibration period of at least 45 mm was allowed
before collections were started. Collection periods
were of 10 mm duration. The following groups of
animals were studied:
Group I. Eighteen normal dogs were infused with
0.9 mole of sodium bicarbonate at varying rates to
achieve a stable plasma bicarbonate above 30
mEq/liter and a urine pH between 7.8 and 8.0; three
to four clearance collections were obtained.
Group 2. Thyroparathyroidectomized (TPTX) dogs.
Six normal dogs underwent TPTX 24 hr before the
study. TPTX was considered complete if the serum
calcium dropped at least 2 mg/100 ml. On the day of
the study, these dogs were infused with sodium bi-
carbonate as described in group 1.
Group 3: Phosphate infusion in maximally alkaline
urine. A) Normal dogs. Six normal dogs were infused
with 0.9 mole of sodium bicarbonate in order to
achieve a urine pH between 7.8 and 8.0. After three
control collections, a neutral phosphate solution
(dibasic sodium phosphate-monobasic sodium phos-
phate in a molar ratio of 4: 11) was infused at a rate
of approximately 3tmoles/kg of body wt per mm for
30 to 40 mm. Three to four clearances were obtained
during phosphate infusion. B) Lithium chloride ad-
ministration. Six normal dogs were treated with i.p.
injected lithium chloride (LiCl), 3 mEq/kg of body
wt, daily for three days, inclusive of the day of study.
Sodium bicarbonate was then infused, as in group 1.
After three collection periods, neutral phosphate was
infused as described in group 3, and three to four
additional collections were obtained.
Group 4: Phosphate infusion in moderately alkaline
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normal and lithium-treated dogs infused with phosphate in highly alkaline urinea
UB UPO4 UPO4V
U-PC02 UHCO3 Pco, UHCO3V mmoles/ Hmoles/
Group mm Hg mEq/liter mm Hg iEq/min liter miii
Normal (N = 18) 75.0 + 4.1
NS
215.8 + 21.9
NS
34.5 + 4.1
NS
496.3 + 61.4
P<0.0l
12.0 + 1.9
P<0.0l
27.6 + 3.7
P<0.0I
TPTX (N = 6) 75.8 5.1 217.9 + 37.3 31.5 6.2 130.7 + 15.4 1.1 0.3 0.66 0.12
Normal + PU4 (N =
Control
6) 72.6 + 5.5
NS
174.4 + 27.6
NS
31.8 + 5.7
NS
941.8 + 162.6
NS
9.0 + 2.5
P<0.02
48.6 + 4.9
P<0.Ol
P04 75.7 5.9 l56.4 20.7 32.9 4.7 703.8 + 117.5 22.2 + 5.6 99.9 + 11.7
Li + P04 (N = 6)
Control 46.0 0.8
NS
87.1 + 3.6
NS
7.4 1.3
NS
1027.8 + 227.2
NS
0.84 0.16
P<0.Ol
9.9 2.0
P<0.OOl
P0, 46.0 1.1 90.4 + 5.9 6.8 1.2 840.7 + 165.1 10.0 + 1.7 93.0 + 8.7
IJHCO3V = urinacy HCO3 concentration and excretion, respectively; UPO4 and UPO4V = urinary phosphorous con-
urine. A) Unilateral ureteral obstruction (UUO).
Twenty-four hours prior to the study, six normal
dogs while under anesthesia had their right ureter
ligated completely. On the day of the study, both
ureters were identified and cannulated. Collection pe-
riods were started when the urine flow of both kid-
neys had stabilized. Sodium bicarbonate was then
infused to achieve a stable urine pH between 6.8 and
7.4. After three control periods, a neutral phosphate
solution was infused as in group 3. Three to four
clearances were obtained during the phosphate in-
fusion. B) Lithium chloride administration. Six normal
dogs were infused with neutral phosphate as de-
scribed in group 3. Three to four clearance collections
were obtained. One week later these dogs were
treated with lithium chloride, as in groups 3A and B.
They were then infused with neutral phosphate, and
three clearance collections were obtained.
Six additional lithium-treated dogs were studied.
In these animals, neutral phosphate was not infused,
Five normal dogs were infused with 0.9 mole of
sodium bicarbonate in order to achieve a stable urine
pH between 6.8 and 7.4. After urine had stabilized,
three clearance collections were obtained.
Group 5: A cute reduction of GFR. A) Thoracic infe-
rior vena cava constriction (TIVCC). Five normal
dogs were infused with sodium bicarbonate as in
group 1, and three clearance collections were ob-
tained. The thoracic inferior vena cava was then par-
tially occluded in order to raise venous pressure to
about 12 cm of water. After urine flow had become
stable, three to four clearance collections were ob-
tained. B) Acute elevation of ureteral pressure. In five
normal dogs, the left ureter was identified and can-
nulated. After the urine flow was stable, they were
infused with sodium bicarbonate as in group 1, and
three collections were obtained. The ureteral pressure
was then elevated to 60 to 80 cm H20 by placing the
ureteral catheter in vertical position. Three additional
collections were obtained during elevation of the ure-
teral pressure.
Group 6: Selective aldosierone deficiency. Eleven
dogs were submitted to bilateral adrenalectomy. Af-
ter surgery they were started on dexamethasone re-
placement (0.75 mg, twice daily) and were fed a nor-
mal kennel diet. These animals were studied four
days after surgery. They were infused with sodium
bicarbonate, as in group 1, and three to four clear-
ance periods were obtained.
Group 7: Hyperkalemia. Six normal dogs were in-
fused with 0.9 mole of sodium bicarbonate at I
mI/mm. After three to four control periods were
obtained, 1 mole of potassium bicarbonate was
infused at 1 mI/mm, and further collections were
done.
Specimen collection, GFR, plasma and urinary
electrolyte determinations, and statistical analyses
were performed as previously described [7]. Data are
presented as mean + SEM. The values presented in
Tables I through 5 represent the mean of all clear-
ance periods.
Results
Administration of sodium bicarbonate to normal
dogs was associated with a high urinary-blood (U-B)
Pco2 gradient (Table I). In TPTX dogs, U-B PCO2
was also high and not significantly different than that
of normal dogs (Table I). Urinary phosphate concen-
tration and excretion were significantly lower in
TPTX dogs than in normal dogs. Thus, TPTX dogs
were able to raise urinary PCO2 during sodium bi-
carbonate administration despite the fact that urinary
phosphate concentration was almost twenty times
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UHCO3, mEq/Iiter
Fig. 1. Urine-blood (U-B)Pc02 plotted against urinary bicarbonate
concentration (UHCO3). Urinary pH was between 6.0 and 8.0.
lower than that of normal animals. The correlation
between the U-B Pco2 and urinary phosphate con-
centrations was poor (r = 0.36).
To further define the role of urinary phosphate on
urinary Pco2, neutral phosphate was infused to nor-
mal dogs with maximally alkaline urines. In the nor-
mal dogs, phosphate infusion failed to increase U-B
Pco2 to a value greater than that observed with so-
dium bicarbonate alone, despite a significant increase
in urinary phosphate concentration and excretion
(Table 1).
Lithium administration resulted in the develop-
ment of hyperchloremic metabolic acidosis with an
alkaline urine (Table 2). U-B Pco2 in lithium-treated
animals with maximally alkaline urine was signifi-
cantly lower than that of normal animals (Table 1).
Phosphate administration failed, as in the normal
animals, to raise U-B Pco2.
In normal dogs with moderately alkaline urines, U-
B Pco2 was significantly lower than in normal dogs
0 Normal
A Normal + phosphate infusion
•• 0
4'O 6
UHCO3, rnEq/Iiter
Fig. 3. Urine-blood (U-B) Pco2 in the postobstructed kidney before
and during phosphate infusion. Urine pH was in the range of 6.8 to
7.4.
with maximally alkaline urines (Table 3). U-B Pc02 is
plotted against urinary bicarbonate concentration(UHCO3) in Figure 1. It is clear that U-B Pco2 is
linearly related to UHCO3 (y 2.8 + 0.15; P <
0.001, r = 0.88). The results obtained in normal,
UUO dogs and lithium-treated dogs with moderately
alkaline urine are shown in Table 3 and Figures 2-4.
Phosphate administration resulted in a significant in-
crease of U-B Pco2 in the control kidney (CK) of
animals with UUO and in normal dogs (Fig. 2). In
contrast, the post-obstructed kidney (P0K) failed to
raise U-B Pco2 with the phosphate infusion (Fig. 3).
The results from the lithium-treated animals infused
with phosphate are shown in Fig. 4. These dogs had a
significant increase in U-B Pco2 following the phos-
phate infusion: it was similar to that seen in normal
kidneys and higher than that of normal animals and
0 20 40 60 80
UHCO3, mEq/Iiter
Fig. 2. Urine-blood (U-B) Pco2 plotted against urinary bicarbonate
concentration (UHCO) in normal dogs before and during phosphate
infusion. Data of control kidney of unilateral ureteral obstruction
(UUO) are also included. Urine pH was in the range of 6.8 to 7.4.
20 I I I
0 20 40 60
UHCO3, mEq//iter
Fig. 4. Urine-blood (U-B) Pco2 in lithium-treated dogs infused with
phosphate and in normal dogs not infused with phosphate. Urine pH
was between 6.8 and 7.4.
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lithium-treated dogs not infused with phosphate. In
contrast, phosphate infusion to lithium-treated dogs
with maximally alkaline urine had no effect on
urinary Pco2 (Table I). The lithium-treated dogs also
were studied prior to lithium administration with
phosphate infusion. The results obtained in these
dogs are shown in Fig. 5. In dogs with moderately
alkaline urine, phosphate infusion was associated
with a high U-B Pco2. U-B Pco2 in these dogs was
not significantly different than that obtained in the
CK of LJUO dogs. In normal dogs with an acid urine,
phosphate infusion had no effect on urinary Pco2.
Thus, phosphate infusion raised U-B Pco2 only
when urine was moderately alkaline.
Table 4 shows the results obtained in animals
with acute thoracic inferior vena cava constriction
(TIVCC) and elevation of the ureteral pressure. Ele-
vation of ureteral pressure led to a significant de-
crease in urine flow, GFR, bicarbonate excretion and
phosphate excretion, but U-B Pco2 remained high.
U-B Pco2 was unaffected by the decrease in GFR and
the decrease in bicarbonate and phosphate excretion.
Acute TIVCC also resulted in a significant decrease
in bicarbonate excretion and GFR, but U-B Pco2
remained unchanged. Thus, decreases in GFR and
distal delivery did not impair the capacity of the
formation of a high urinary Pco2 provided the urine
was maximally alkaline.
The results obtained in hyperkalemic and adrena-
lectomized dogs are shown in Table 5. Plasma potas-
sium increased from 2.9 0.23 to 7.9 0.68
mEq/liter, P < 0.01, following potassium bicarbo-
nate infusion. It is obvious that hyperkalemia and
aldosterone deficiency did not impair generation of a
high U-B Pco2 when the urine was highly alkaline.
Discussion
A) Factors influencing the formation of urinary
Pco2. Our results demonstrate that a high urinary
Pco2 is always present, provided the urine is highly
alkaline and the distal acidification mechanism is in-
tact. The achievement of a high urinary Pco2 under
these conditions is, contrary to previous suggestions,
uninfluenced by decreases in urine flow rate, distal
delivery of bicarbonate, GFR, urinary phosphate
concentration and excretion, and serum potassium
levels [3, 8—14]. These observations are in complete
agreement with the data recently reported in abstract
form by Stinebaugh et al [15].
Portwood et al demonstrated that U-B Pco2 was
related to bicarbonate excretion levels, and a max-
imal U-B Pco2 was achieved when bicarbonate excre-
tion was approximately 300 tEq/min [11]. Our data
show that U-B Pco2 is high regardless of whether
bicarbonate excretion remains constant or decreases,
provided the urine is highly alkaline, Indeed, U-B
Pco2 was linearly related to urinary bicarbonate con-
centration over a range of urinary pH of 6.8 to 8.0 in
Urine
flow
mI/mm
GFR
mi/mm
Plasma
HCO3
mEq/iiier
Pco2
mm Hg
Urine
pH
Control 3.2 1.2 60.8 4.8 30.2 1.3 43.0 + 2.5 7.95 + 0.03
TIVCC (N = 5) NS P < 0.02 NS NS NS
Exp. 1.5 0.3 36.9 + 7.3 34.1 1.8 39.9 1.0 7.98 0.03
Control
Elev UP5 (N = 5)
3.9 0.2
P < 0.001
24.5 2.7
P< 0.02
39.7 + 2.0
NS
39.5 1.5
NS
7.87 + 0.02
NS
Exp. 1.3 + 0.2 11.0 + 2.1 45.2 2.7 42.3 + 2.0 7.94 0.01
a GFR = glomerular lIltration rate: P0 and U-P0 = arterial blood and urine CO2 tension, respectively:
phosphorus concentration and excretion, respectively: Exp. = experimental group: N number of animals.
The data of elevation of uretral pressure refer to one kidney only.
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Fig. 5. Urine-blood (U-B) Pco2 during phosphate infusion in normal
dogs and alter lithium administration in the same dogs.
Table 4. Effect of acute thoracic inferior vena cava constriction
Urinary PC02 and renal acid(fication 313
normal dogs. In renal tubular acidosis, a highly alka-
line urine can be achieved, but urinary Pco2 fails to
rise. Since urine pH is proportional to log bicarbo-
nate/Pco2, the failure of Pco2 to rise in the presence
of maximally alkaline urine results in an obligatory
reduction in urinary bicarbonate concentration.
Thus, the ability to raise urinary bicarbonate concen-
tration in maximally alkaline urine is dependent on
the capacity to raise urinary Pco2.
On the other hand, the ability to raise urinary Pco2
in highly alkaline urine is dependent on its capacity to
raise urinary bicarbonate concentration (Fig. 1). The
experimental distal acidification defects described
here, as well as other distal acidification defects, are
associated with impaired concentrating ability [5, 38].
This concentrating defect induces a decrease in
urinary bicarbonate concentration and may thus pre-
vent the rise in urinary Pco2. Based on these clear-
ance studies, it is obviously impossible to determine if
the primary defect is the inability to raise the urinary
Pco2 or if the concentrating defect, by causing a
reduction in urinary bicarbonate, secondarily reduces
the urinary Pco. It is possible, however, that patients
with distal renal tubular acidosis may be able to raise
urinary bicarbonate concentration, despite the failure
to raise urinary Pco2 if they are able to attain urine
pH values higher than those of normal subjects. Up
to the present time, no studies have been done to
determine whether patients with distal rçnal tubular
acidosis can attain higher urine pH values than those
seen in normal subjects.
In moderately alkaline urine, however, it is obvious
that the failure of urinary Pco2 to rise with phosphate
infusion cannot be attributed to the inability to in-
crease bicarbonate concentration. The amount of
bicarbonate present at this urine pH is too small to
account for the increase in urinary Pco2; phosphate
infusion, perhaps by stimulating hydrogen ion secre-
tion, raises urinary Pco2 in normal and lithium-
(TIVCC) and ureteral pressure elevation (Elev UP) on urinary Pco2
treated dogs, but fails to elicit the same response in
the post-obstructed kidney. These observations sug-
gest that in moderately alkaline urine hydrogen ion
secretion is essential for the elevation of urinary
Pco2.
Our finding that a high U-B Pco2 is achieved in the
presence of a very low concentration of phosphate is
in complete agreement with the data reported by
Portwood et al [11] and Rector, Porter, and Seldin [14].
On the other hand, Kennedy, Orloff, and Berliner
demonstrated that urinary Pco2 is directly related to
urinary buffer concentration [3]. Other investigators
have also indicated that the presence of phosphate is
essential for generation of high urinary Pco2 and that
increased excretion of phosphate is associated with a
further rise in urinary Pco2 [11]. Our data failed to
demonstrate any effect of phosphate on urinary Pco2
when urine pH was highly alkaline (7.8 to 8.0),
despite increases in phosphate excretion of up to
l0Opmoles/min. It is possible, though unlikely, that
greater increases in phosphate excretion, similar to
those obtained by Kennedy et al, would result in an
increase in urinary Pco2 in highly alkaline urine.
Infusion of phosphate to animals with lower urine
pH (6.8 to 7.4), however, resulted in a definite in-
crease in urinary Pco2. These observations seem to
contradict the data reported by Kennedy et al dem-
onstrating that urinary Pco2 is directly related to
buffer concentration [3]. It should be pointed out,
however, that close analysis of their data suggests
that the relationship between urine Pco2 and buffer
concentration can be explained by the fact that urine
bicarbonate concentration was increasing during the
course of the study, although this impression cannot
be verified with certainty. In the study of Kennedy et
al [3], at a constant urine pH of about 8.0, the range
of urinary Pco2 at low and high phosphate concen-
trations overlaps considerably, while at a lower urine
pH, e.g., 6.8 to 7.4, the animals with high phosphate
U-B
UpCO2
mm Hg
UHCO3
mEq//iter
pCO2
mm Hg
UHCO3V
,.iEq/min
UPO4
mmoles/Iiter
UPO4V
imo1es/min
Control 76.2 + 5.5 187.2 + 30.5 33.2 + 6.8 599.0 135.1
TIVCC (N = 5) NS NS NS P<0.05
Exp. 68.6 + 5.8 169.7 + 28.2 28.7 + 5.7 254.6 + 82.3
Control 65.3 3.8 118.9 + 8.3 25.8 + 2.7 463.7 + 80.2 3.5 + 0.7 13.7 2.5
Elev UPb (N
Exp.
= 5) NS
75.8 + 3.2
P < 0.02
168.0 8.9
NS
33.5 4.7
P < 0.05
218.4 + 57.4
NS
3.9 + 6.3
P < 0.02
5.1 0.8
U1-1C03 and UHCO3V = urinary HCO3 concentration and excretion, respectively UPO4 and UPOV = urinary
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Table 5. Urinary Pco2 in adrenalectomized, (ADX) and hyperkalemic (TK) dogs
Urine
flow
mi/mm
GFR
mi/mm
Plasma
HCO3
mEq/iiter
Plasma
Pco2
mm Hg
Urine
pH
U-Po
mm Hg
UHCO3
mEq/iiter
U-B
Pco2
mm Hg
UHCO,V
.tEq/min
ADXb (N= 11)
1K (N=6):
Control
Exp.
2.3 + 0.3
NS
1.7 + 0.2
P<0.Ol
2.9 1.2
34.3 + 3.7
P <0.01
36.1 + 4.8
NS
33.9 2.7
39.5 + 2.0
P < 0.05
34.6 + 1.4
NS
36.4 1.3
41.4 1.9
NS
41.5 + 1.3
NS
40.7 1.3
7.92 0.02
P < 0.02
8.03 + 0.02
NS
8.02 0.03
65.4 + 4.4
NS
68.1 3.5
NS
68.9 4.7
139.8 + 13.7
P < 0.05
181.6 + 10.4
NS
171.3 + 13.7
24.0 5.1
NS
26.6 + 2.6
NS
28.2 + 3.9
321.5 55.0
NS
308.7 + 34.9
P<0.05
496.8 66.5
a GFR = glomerular filtration rate; Pco2 and U-Pc02 = arterial blood and urine CO2 tension, respectively; IJHCO3 and IJHCO3V =
urinary HCO3 concentration and excretion, respectively; UPO4 and UPO4V = urinary phosphate concentration and excretion, respectively;
Exp. = experimental group.
The data of ADX dogs are compared to that of normal dogs in Table I.
concentration have a distinctly higher value of urinary
Pco2. Dorman, Sullivan, and Pitts demonstrated that
variations of one hundred-fold in urinary phosphate
concentration did not influence urinary Pco2 [16].
Their data, however, are difficult to interpret since
plasma Pco2 was high and U-B Pco2 was quite low
before and after phosphate infusion, All investigators
who found an effect of phosphate infusion on urinary
Pco2 in dogs, normal subjects, and in patients with
distal renal tubular acidosis (RTA) have worked in
the pH range close to the pK (6.8) of phosphate [3,
II, 17, 18]. More recently, Stinebaugh et al showed a
significant effect of phosphate infusion on urinary
Pco2; no urine pH data, however, are reported [19].
B) Mechanism of formation of high urinary Pco2.
Rector [20] has discussed in detail the mechanisms
responsible for the formation of a high urinary Pco2
during sodium bicarbonate administration. The high
urinary Pco2 has been attributed to delayed dehy-
dration of carbonic acid in the distal nephron, since
carbonic anhydrase infusion abolishes the high urine-
blood Pco2 gradient [2, 20, 21]. In the absence of
buffer, a very large disequilibrium in the collecting
duct (2.6 pH units below the final urine) would be
required to generate the high urinary Pco2 observed
[20]. The small disequilibrium measured in the distal
tubule, as well as the extremely rapid dehydration
constant of carbonic acid, make this explanation un-
likely [22-24]. The demonstration that the Pco2 of the
collecting duct is 40 mm Hg higher than the Pco2 of
vasa recta argues against the medullary trapping of
CO2 as the determining factor for high urinary Pco2
[25]. Kennedy et al and Rector [3, 20] have suggested
that a much smaller disequilibrium pH would be
required to generate the high urinary PC02 if the urine
contains sufficient amount of non-bicarbonate buf-
fers. These non-bicarbonate buffers would donate hy.
drogen ions which react with bicarbonate ions yield-
ing carbonic acid. If this were the case, one would
expect phosphate infusion in animals with highly al-
kaline urine to result in additional increases in
urinary Pco2. Our results demonstrate that increases
in phosphate excretion up to 100moles/min do not
influence urinary Pco2.
If the disequilibrium pH in the collecting duct is of
small magnitude (e.g., 0.2), the pH of the collecting
duct would be 7.8 and the pH of the final urine, 8.0.
At pH of 7.8, 91% of phosphate exists in the form of
dibasic sodium phosphate (Na2HPO4) (pK of phos-
phate system = 6.8). As the pH of the collecting duct
proceeds towards equilibrium (8.0), only 4% of mono-
basic sodium phosphate (NaH2PO2) changes to di-
basic sodium phosphate. The results of Portwood
et al [11] and Rector et al [14], as well as ours, demon-
strate that the urinary Pco2 is high when urine con-
tains only I mmole/liter of phosphate; this means that
only 40moles of monobasic sodium phosphate is
titrated in the collecting duct as the pH of this fluid
increases from 7.8 to 8.0. Therefore, when the col-
lecting duct fluid achieves equilibrium, 40imoles of
sodium bicarbonate will react with 40.tmoles of
monobasic sodium phosphate, yielding 40moles of
carbonic acid which would raise urine PCO2 by
approximately 1.3 mm Hg. Thus, these theoretical
considerations, as well as the data showing no
effect of phosphate infusion on urinary Pco2 at
a high pH, cast doubt on the role of phosphate
in determining urinary Pco2 in highly alkaline
urines. These data, however, do not exclude that high
urinary Pco2 results from delayed dehydration of
carbonic acid. It is possible that other buffers of
appropriate pK may provide enough hydrogen ions
to react with bicarbonate ions and result in higher
urinary Pco2 values [9]. Since urinary buffer strength
was not measured in these experiments, it cannot be
excluded that some buffers, e.g., amino acids, may
have the appropriate pK and be present in the right
amounts to yield sufficient hydrogen ions to raise
urinary Pco2.
Another explanation for the formation of urinary
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Pco2 in highly alkaline urine is also possible. It has
been assumed that the diffusion of carbon dioxide
across cell membranes in vivo is as rapid as in in vitro.
It has been demonstrated, however, that diffusion of
carbon dioxide across monolipid layers is partially
restrained [26]. Carbonic anhydrase has been shown
to accelerate carbon dioxide transfer across mem-
branes [27]; there is also evidence that acetazolamide
impairs carbon dioxide diffusion across membranes
[28]. Indirect evidence, now available, suggests that a
high carbon dioxide tension may be present in tubu-
lar fluid in the early proximal tubule, whereas in the
late proximal tubular fluid the carbon dioxide tension
is equal to that of plasma [29—31]. The decrease in
carbon dioxide tension to plasma levels by the end of
the proximal tubule could be ascribed to the decrease
in bicarbonate concentration as well as diffusion of
carbon dioxide due to a favorable surface-volume
relationship. It is possible that similar restrictions tt5
carbon dioxide diffusion exist in the collecting duct
and could account for the high urinary Pco2 during
bicarbonate-loading. This hypothesis would require a
much lower disequilibrium pH to yield the high
urinary carbon dioxide tension of highly alkaline
urine. According to this hypothesis, buffer excretion
or concentration would play no role in the formation
of urinary Pco2 at a high urinary pH (7.8 to 8.0). It is
also worthy of note that carbonic anhydrase, at least
in vitro, accelerates transfer of carbon dioxide across
membranes [27]. The abolition of urine-plasma car-
bon dioxide gradients by carbonic anhydrase could
be explained by accelerated diffusion of the carbon
dioxide across the tubular membrane, in addition to
whatever effect the drug exerts on the rate of dehy-
dration of carbonic acid. The hypothesis that restric-
tion of carbon dioxide diffusion across the collecting
duct accounts for the high urinary Pc02 during so-
dium bicarbonate administration awaits direct mea-
surement of carbon dioxide tension in the collecting
duct.
Phosphate infusion had a distinct effect on urinary
Pco2 when the urine pH was close to the pK of the
phosphate system (6.8). At a urine pH of 6.8, 50% of
the phosphate exists as monobasic sodium phosphate
(NaH2PO4), and at a urine p1-I of 7.4, 20% of total
phosphate is in the form of monobasic sodium phos-
phate. The amount of bicarbonate and carbonic acid
present in the urine at this pH range is clearly not
sufficient to raise the urinary Pco2.
It is well established that phosphate is a poorly
reabsorbable anion in the distal nephron and thereby
can stimulate hydrogen ion secretion [32, 33]. Two
possible mechanisms may account for the effect of
phosphate on urinary Pco2; first, hydrogen ion secre-
tion is enhanced, and second, hydrogen ion secretion
is apportioned between the bicarbonate and phos-
phate [3, 32]. The latter event will retard the forma-
tion of carbonic acid by increasing the time required
for the reaction between bicarbonate and phosphate
to come into equilibrium [3]. This will "delay" the
dehydration of carbonic acid and result in a high
urinary PC02.
C) Urinary Pco2 in renal tubular acidosis. We have
previously demonstrated that urinary Pco2 is abnor-
mally low in both the post-obstructed kidney and in
lithium-treated dogs; sodium sulfate infusion lowered
urine pH in the lithium-treated dogs but failed to
elicit the same response in the post-obstructed kidney
[34, 35]. In the present study, we demonstrate that
phosphate infusion increases urinary Pco2 in the nor-
mal kidney and in lithium-treated dogs but fails to
raise urinary Pco2 in the post-obstructed kidney.
Phosphate infusion to lithium-treated dogs with
moderately alkaline urine increased urinary Pco2 pre-
sumably by stimulating hydrogen ion secretion; the
hydrogen ion secreted would be apportioned between
bicarbonate and phosphate. The latter event would
"delay" the dehydration of carbonic acid by increas-
ing the time for the reaction between bicarbonate and
monobasic sodium phosphate to come into equilib-
rium, and thus results in a high urinary Pco2.
The effects of phosphate infusion on urinary Pco2
when the urine was moderately alkaline were quite
similar to the effects of sodium sulfate infusion on
urinary acidification. The results of the present study,
together with our previous observations, demonstrate
the existence of two types of experimental distal acid-
ification defects. Both defects are associated with a
low urinary Pco2 in highly alkaline urine; one defect
is associated with the ability to lower urine pH with
sodium sulfate infusion and to raise urinary Pco2
with phosphate administration, whereas the second
fails to respond to both agents. We suggest that the
acidification defect associated with a normal response
to sodium sulfate infusion and to phosphate infusion
represents increased hydrogen ion back diffusion
(gradient type), whereas the failure to respond to
sodium sulfate and phosphate represents impaired
hydrogen secretion (secretory type).
It is possible that more than one mechanism is
responsible for the failure of patients with distal renal
tubular acidosis to raise urinary Pco2 with sodium
bicarbonate administration. There are only seven
patients with distal renal tubular acidosis reported in
the literature that were studied with sodium sulfate
infusion; in two of these patients acidification was
normal [38—41]. Few patients with distal renal tubu-
lar acidosis have been infused with phosphate; several
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patients raised urinary Pco2, whereas in others
urinary Pco2 was unchanged [17, 18, 43]. It is, there-
fore, possible that in some patients with distal renal
tubular acidosis the acidification defect is caused by
increased acid back diffusion, whereas in the others
hydrogen ion secretion is impaired. We suggest that
sodium sulfate and phosphate administration might
allow distinction of these two mechanisms. Further
studies in patients with distal renal tubular acidosis
are needed in order to test the validity of this pro-
posal.
Other defects in acidification (e.g., impaired am-
monia production) should not be associated with
impaired urinary carbon dioxide formation. Alkalini-
zation of the urine of dogs with selective aldosterone
deficiency led to a normal rise in urinary Pco2. This
observation suggests that distal hydrogen ion secre-
tion is intact in selective aldosterone deficiency. The
mechanism responsible for the metabolic acidosis in
aldosterone deficiency is yet unclear, but it may be
related to defective ammonia production, occurring
either as a result of aldosterone deficiency or as a
consequence of hyperkalemia [43, 44].
In conclusion, urinary Pco2 in highly alkaline urine
is a useful measure of distal acidification. The failure
of urinary Pco2 to rise under these conditions reflects
a distal acidification defect; this defect may be due
either to impaired hydrogen ion secretion or excessive
back diffusion of hydrogen ion. Phosphate infusion
increases urinary Pco2 when urine is in the range of
6.8 to 7.4 but fails to elicit the same response in highly
alkaline urine. In the presence of an acidification
defect, phosphate infusion likely raises urinary Pco2
when the defect is of the gradient type. The high
urinary carbon dioxide tension of highly alkaline
urine may be due to impaired diffusion of carbon
dioxide across the collecting duct.
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